Cargando…
Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma
Oral tongue squamous cell carcinoma (OTSCC) is one of the most common head and neck cancers. Innate or acquired resistance to cisplatin, a standard chemotherapy agent for OTSCC, is common in patients with OTSCC. Understanding the molecular basis for cisplatin chemoresistance in OTSCC cells may serve...
Autores principales: | Zhou, Yueying, Zhang, Leiyi, Pan, Hao, Wang, Baisheng, Yan, Fei, Fang, Xiaodan, Munnee, Krishna, Tang, Zhangui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411128/ https://www.ncbi.nlm.nih.gov/pubmed/25915207 http://dx.doi.org/10.1371/journal.pone.0123208 |
Ejemplares similares
-
Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery: A Systematic Review and Meta-analysis
por: Munnee, Krishna, et al.
Publicado: (2016) -
Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2
por: Itai, Shunsuke, et al.
Publicado: (2018) -
Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma
por: Pan, Hao, et al.
Publicado: (2017) -
Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
por: Häyry, V, et al.
Publicado: (2010) -
MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy
por: Cheng, Yuxi, et al.
Publicado: (2022)